Preferred Label : Legius syndrome;
Symbol : LGSS;
CISMeF acronym : NFLS; LGSS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : NFLS; Neurofibromatosis type 1-like syndrome;
Description : Legius syndrome is an autosomal dominant disorder that shows some similarities to
neurofibromatosis type I (NF1; 162200), which is caused by mutation in the neurofibromin
gene (613113); however, Legius syndrome is less severe. Individuals with Legius syndrome
typically have multiple cafe-au-lait spots, sometimes associated with skin fold freckling,
variable dysmorphic features such as hypertelorism or macrocephaly, lipomas, and mild
learning disabilities or attention problems. Legius syndrome is not associated with
neurofibromas, optic gliomas, Lisch nodules, or tumor predisposition. The SPRED1 gene
encodes a negative regulator of the RAS-MAPK pathway, similar to neurofibromin, and
thus may be considered a RASopathy (review by Brems et al., 2012).;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the sprouty-related EVH1 domain-containing protein 1 gene (SPRED1,
609291.0001);
Prefixed ID : #611431;
Origin ID : 611431;
UMLS CUI : C1969623;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)